Back

Benefits of systematic screening for Atrial Fibrillation - the STROKESTOP-study

23 April 2021 (18:06 - 18:12)
Organised by:
Congress Presentation Part of: Late Breaking Clinical Trials Stroke Prevention EHRA Premium Access EHRA 2021

About the speaker

Photo
Doctor Emma Svennberg

Karolinska Institute, Stockholm (Sweden)

3 More presentations in this session

Presentation thumbnail
Targeted therapy of underlying conditions in patients with persistent atrial fibrillation and mild to moderate stable heart failure: long term outcome of the RACE 3 Trial
Professor M. Rienstra (Groningen, NL)
Slides Video
Presentation thumbnail
Long term efficacy and final outcomes of the subcutaneous implantable cardioverter-defibrillator registry
Professor P. Lambiase (London, GB)
Slides Video
Presentation thumbnail
Early treatment of atrial fibrillation for stroke prevention trial
Doctor A. Metzner (Hamburg, DE)
Slides Video

Access the full session

Session thumbnail
Late Breaking Clinical Trials

The Event

Event poster

EHRA 2021

23 April 2021 18:06 CET
You may be interested in
thumbnail
Congress Session
Stroke prevention in clinical and subclinical atrial fibrillation
thumbnail
Congress Session
Oral anticoagulation in subclinical atrial fibrillation
thumbnail
Congress Session
EHRA Myths - Device-detected atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources